BATS BZX Real-Time Price
As of 12:52pm ET
| +0.82 / +1.88%|
The 26 analysts offering 12-month price forecasts for GlaxoSmithKline have a median target of 46.42, with a high estimate of 56.74 and a low estimate of 33.44. The median estimate represents a +4.45% increase from the last price of 44.44.
The current consensus among 29 polled investment analysts is to Buy stock in GlaxoSmithKline. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.